{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T22:08:23Z","timestamp":1785276503903,"version":"3.55.0"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T00:00:00Z","timestamp":1663891200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Toxic epidermal necrolysis (TEN) and Stevens\u2013Johnson syndrome (SJS) are acute inflammatory skin adverse reactions characterized by epidermal exfoliation and multi-site mucositis and are considered medical emergencies. The risk factors for SJS\/TEN include immune disorders, malignancy, and genetic susceptibility. In most cases, medication is considered to be the leading cause of TEN. In addition, several studies suggest that infections, such as the herpes simplex virus, human immunodeficiency virus (HIV), <jats:italic>Mycoplasma pneumoniae<\/jats:italic>, streptococcus, and meningococcus infections, can trigger the occurrence of SJS\/TEN. In this rare case, we share our experience managing TEN in a hepatitis A virus infection with an acute-on-chronic liver failure patient. A 38-year-old man was infected with hepatitis A virus on the basis of liver cirrhosis and progressed to acute-on-chronic liver failure. As the infection progressed, the target-like skin lesions accompanied by mucosal involvement worsened. The condition of the patient progressively worsened with a severe generalized rash, bullae, and epidermal detachment accompanied by severe erosive mucosal lesions. His skin detachment area gradually involved 30% of the body surface area (BSA), and the disease progressed to TEN. The intravenous infusion of corticosteroids alleviated the patient's hypersensitivity, and the patient obtained lasting remission without severe adverse reactions and complications.<\/jats:p>","DOI":"10.3389\/fmed.2022.964062","type":"journal-article","created":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T05:20:35Z","timestamp":1663910435000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Toxic epidermal necrolysis in hepatitis A infection with acute-on-chronic liver failure: Case report and literature review"],"prefix":"10.3389","volume":"9","author":[{"given":"Xin","family":"Zang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongzhen","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1111\/bjd.14530","article-title":"U.K. guidelines for the management of stevens-johnson syndrome\/toxic epidermal necrolysis in adults 2016","volume":"174","author":"Creamer","year":"2016","journal-title":"Br J Dermatol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.jdermsci.2020.09.009","article-title":"The nationwide epidemiological survey of Stevens-Johnson syndrome and toxic epidermal necrolysis in Japan, 2016\u20132018","volume":"100","author":"Sunaga","year":"2020","journal-title":"J Dermatol Sci."},{"key":"B3","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1097\/00006534-200209010-00008","article-title":"Outcome of patients with toxic epidermal necrolysis syndrome revisited","volume":"110","author":"Ducic","year":"2002","journal-title":"Plast Reconstr Surg."},{"key":"B4","doi-asserted-by":"publisher","first-page":"588063","DOI":"10.3389\/fphar.2021.588063","article-title":"Current pharmacogenetic perspective on stevens-johnson syndrome and toxic epidermal necrolysis","volume":"12","author":"Cheng","year":"2021","journal-title":"Front Pharmacol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s12072-019-09946-3","article-title":"Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (Apasl): an update","volume":"13","author":"Sarin","year":"2019","journal-title":"Hepatol Int."},{"key":"B6","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1097\/00004836-198912000-00020","article-title":"Toxic epidermal necrolysis associated with acute cholestatic viral hepatitis A","volume":"11","author":"Werblowsky-Constantini","year":"1989","journal-title":"J Clin Gastroenterol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/clpt.2009.252","article-title":"Alden, an algorithm for assessment of drug causality in Stevens-Johnson syndrome and toxic epidermal necrolysis: comparison with case-control analysis","volume":"88","author":"Sassolas","year":"2010","journal-title":"Clin Pharmacol Ther."},{"key":"B8","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/1750-1172-5-39","article-title":"Toxic epidermal necrolysis and Stevens-Johnson syndrome","volume":"5","author":"Harr","year":"2010","journal-title":"Orphanet J Rare Dis."},{"key":"B9","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s12016-017-8654-z","article-title":"Current perspectives on Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"54","author":"Lerch","year":"2018","journal-title":"Clin Rev Allergy Immunol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1046\/j.1365-2249.2000.01119.x","article-title":"Blister fluid T lymphocytes during toxic epidermal necrolysis are functional cytotoxic cells which express human natural killer (Nk) inhibitory receptors","volume":"119","author":"Le Cleach","year":"2000","journal-title":"Clin Exp Immunol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/j.jaci.2004.07.047","article-title":"Toxic epidermal necrolysis: effector cells are drug-specific cytotoxic T cells","volume":"114","author":"Nassif","year":"2004","journal-title":"J Allergy Clin Immunol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1038\/nm.1884","article-title":"Granulysin is a key mediator for disseminated keratinocyte death in stevens-johnson syndrome and toxic epidermal necrolysis","volume":"14","author":"Chung","year":"2008","journal-title":"Nat Med."},{"key":"B13","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1365-2230.1997.tb01038.x","article-title":"Increased drug reactions in HIV-1-positive patients: a possible explanation based on patterns of immune dysregulation seen in HIV-1 disease. The Military Medical Consortium for the Advancement of Retroviral Research (MMCARR)","volume":"22","author":"Smith","year":"1997","journal-title":"Clin Exp Dermatol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1016\/j.jaad.2013.12.025","article-title":"HIV infection predisposes skin to toxic epidermal necrolysis via depletion of skin-directed Cd4? T cells","volume":"70","author":"Yang","year":"2014","journal-title":"J Am Acad Dermatol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.hbpd.2019.07.003","article-title":"The immunological roles in acute-on-chronic liver failure: an update","volume":"18","author":"Chen","year":"2019","journal-title":"Hepatobiliary Pancreat Dis Int."},{"key":"B16","doi-asserted-by":"publisher","first-page":"640360","DOI":"10.3389\/fmed.2021.640360","article-title":"Clinical aspects of Stevens-Johnson syndrome and toxic epidermal necrolysis with severe ocular complications in South Korea","volume":"8","author":"Kim","year":"2021","journal-title":"Front Med (Lausanne)."},{"key":"B17","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1001\/jamaophthalmol.2017.0074","article-title":"Human leukocyte antigen class I genes associated with stevens-johnson syndrome and severe ocular complications following use of cold medicine in a Brazilian Population","volume":"135","author":"Wakamatsu","year":"2017","journal-title":"JAMA Ophthalmol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"649661","DOI":"10.3389\/fmed.2021.649661","article-title":"Findings by an International collaboration on SJS\/TEN with severe ocular complications","volume":"8","author":"Ueta","year":"2021","journal-title":"Front Med (Lausanne)."},{"key":"B19","doi-asserted-by":"publisher","first-page":"5981","DOI":"10.1038\/srep05981","article-title":"Trans-ethnic study confirmed independent associations of Hla-a*02:06 and Hla-B*44:03 with cold medicine-related Stevens-Johnson syndrome with severe ocular surface complications","volume":"4","author":"Ueta","year":"2014","journal-title":"Sci Rep."},{"key":"B20","doi-asserted-by":"publisher","first-page":"DES183","DOI":"10.1167\/iovs.17-23537","article-title":"Results of detailed investigations into Stevens-Johnson syndrome with severe ocular complications","volume":"59","author":"Ueta","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B21","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ajo.2015.05.002","article-title":"Predictive factors associated with acute ocular involvement in Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"160","author":"Sotozono","year":"2015","journal-title":"Am J Ophthalmol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.alit.2020.11.004","article-title":"Mortality and risk factors on admission in toxic epidermal necrolysis: a cohort study of 59 patients","volume":"70","author":"Watanabe","year":"2021","journal-title":"Allergol Int."},{"key":"B23","doi-asserted-by":"publisher","first-page":"506","DOI":"10.4103\/0378-6323.113080","article-title":"Low dose intravenous immunoglobulins and steroids in toxic epidermal necrolysis: a prospective comparative open-labelled study of 36 cases","volume":"79","author":"Jagadeesan","year":"2013","journal-title":"Indian J Dermatol Venereol Leprol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jaad.2007.08.039","article-title":"Effects of treatments on the mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis: a retrospective study on patients included in the prospective euroscar study","volume":"58","author":"Schneck","year":"2008","journal-title":"J Am Acad Dermatol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.3389\/fimmu.2019.02490","article-title":"The management of glucocorticoid therapy in liver failure","volume":"10","author":"Xue","year":"2019","journal-title":"Front Immunol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"e14783","DOI":"10.7759\/cureus.14783","article-title":"A case of toxic epidermal necrolysis caused by the use of trimethoprim alone","volume":"13","author":"Sood","year":"2021","journal-title":"Cureus."},{"key":"B27","doi-asserted-by":"publisher","first-page":"636924","DOI":"10.3389\/fmed.2021.636924","article-title":"Recent dermatological treatments for stevens-johnson syndrome and toxic epidermal necrolysis in Japan","volume":"8","author":"Hsieh","year":"2021","journal-title":"Front Med (Lausanne)."},{"key":"B28","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1111\/j.1440-0960.2006.00243.x","article-title":"Severe toxic epidermal necrolysis precipitated by amphetamine use","volume":"47","author":"Roberts","year":"2006","journal-title":"Australas J Dermatol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"274","DOI":"10.4103\/ijd.IJD_217_19","article-title":"Clinical features, risk factors, and prognostic markers of drug-induced liver injury in patients with stevens-johnson syndrome\/toxic epidermal necrolysis","volume":"65","author":"Zhang","year":"2020","journal-title":"Indian J Dermatol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1056\/NEJM198709103171101","article-title":"A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock","volume":"317","author":"Bone","year":"1987","journal-title":"N Engl J Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s13054-017-1659-4","article-title":"Corticosteroids in septic shock: a systematic review and network meta-analysis","volume":"21","author":"Gibbison","year":"2017","journal-title":"Crit Care."},{"key":"B32","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1056\/NEJMoa1705716","article-title":"Hydrocortisone plus fludrocortisone for adults with septic shock","volume":"378","author":"Annane","year":"2018","journal-title":"N Engl J Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"230538","DOI":"10.1136\/bcr-2019-230538","article-title":"Stevens-Johnson syndrome\/toxic epidermal necrolysis: treatment with low-dose corticosteroids, vitamin C and thiamine","volume":"12","author":"Middendorf","year":"2019","journal-title":"BMJ Case Rep"},{"key":"B34","doi-asserted-by":"publisher","first-page":"202","DOI":"10.3390\/microorganisms9010202","article-title":"Impact of antibiotics associated with the development of toxic epidermal necrolysis on early and late-onset infectious complications","volume":"9","author":"Lipovy","year":"2021","journal-title":"Microorganisms"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1016\/j.burns.2013.03.011","article-title":"27 years of a single burn centre experience with Stevens-Johnson syndrome and toxic epidermal necrolysis: analysis of mortality risk for causative agents","volume":"39","author":"Weinand","year":"2013","journal-title":"Burns."},{"key":"B36","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1586\/eci.11.66","article-title":"The current understanding of Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"7","author":"Mockenhaupt","year":"2011","journal-title":"Expert Rev Clin Immunol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/j.ajo.2008.12.040","article-title":"Successful treatment of Stevens-Johnson syndrome with steroid pulse therapy at disease onset","volume":"147","author":"Araki","year":"2009","journal-title":"Am J Ophthalmol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"e17215","DOI":"10.7759\/cureus.17215","article-title":"Toxic epidermal necrolysis post COVID-19 vaccination\u2014first reported case","volume":"13","author":"Bakir","year":"2021","journal-title":"Cureus."},{"key":"B39","doi-asserted-by":"publisher","first-page":"e139","DOI":"10.1016\/j.oooo.2021.06.019","article-title":"Stevens-Johnson syndrome post second dose of pfizer COVID-19 vaccine: a case report","volume":"132","author":"Elboraey","year":"2021","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.964062\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T05:20:38Z","timestamp":1663910438000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.964062\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,23]]},"references-count":39,"alternative-id":["10.3389\/fmed.2022.964062"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.964062","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,23]]},"article-number":"964062"}}